All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Recovery comparison

Angiotensin-(1-7) vs Larazotide

An educational, source-based comparison of Angiotensin-(1-7) and Larazotide — how each peptide works, what it's researched for, and what to know before going deeper.

Cardiovascular · Anti-inflammatory
Angiotensin-(1-7)

Counter-regulatory peptide of the renin-angiotensin system.

Mechanism

A heptapeptide of the renin-angiotensin system that acts on Mas receptors. Research demonstrates counter-regulatory effects to angiotensin II, promoting vasodilation, anti-inflammatory signaling, and anti-fibrotic effects in cardiovascular and renal tissues.

Research areas
  • Pulmonary hypertension and fibrosis
  • Heart failure with preserved ejection fraction
  • Acute lung injury and ARDS
  • Diabetic nephropathy
Considerations
  • Investigational; not FDA-approved.
  • Interaction with ACE inhibitors and ARBs requires careful study design.
Full Angiotensin-(1-7) profile →
Gastrointestinal · Barrier
Larazotide

Tight junction regulator studied for celiac disease.

Mechanism

An octapeptide zonulin antagonist that helps maintain intestinal tight junction integrity, reducing paracellular permeability triggered by gluten in celiac disease.

Research areas
  • Celiac disease (Phase 3 completed)
  • Intestinal barrier function ('leaky gut' research)
  • Environmental enteropathy
Considerations
  • Not yet FDA-approved.
  • Investigational; physician oversight required.
Full Larazotide profile →

Angiotensin-(1-7) vs Larazotide — Key differences

  • Class: Angiotensin-(1-7) is classified as Cardiovascular · Anti-inflammatory, while Larazotide is Gastrointestinal · Barrier.
  • Primary research focus: Angiotensin-(1-7)pulmonary hypertension and fibrosis; Larazotideceliac disease (phase 3 completed).
  • Tag: Cardiovascular · Anti-inflammatory vs Gut.

Related comparisons